Investment
Features
FeesSafety
Academy
More
Pluang+

Phillips Edison sees record leasing strength and strong acquisition market with 9% unlevered IRRs.

Market News
15 Sep 2026
Seeking Alpha
View Source
Bullish
Phillips Edison sees record leasing strength and strong acquisition market with 9% unlevered IRRs.

Phillips Edison & Company reports one of the best operating environments with record-high leasing occupancy, margins, and activity. The company is experiencing a strong acquisition market, buying properties at a 6.7% initial yield and achieving 9% unlevered internal rates of return (IRRs). They are selling assets at a 5.9% yield, indicating favorable buy-sell spreads. This robust market dynamic supports continued growth and profitability for the company.

Phillips Edison & Company, Inc. is the subject of this market context snapshot. For readers following US Real Estate stocks, here is Pluang's market snapshot as of Sep 16, 2026 03:22 WIB: Of 22 priced Real Estate-sector US stocks tradable on Pluang, 10 rose and 12 fell today. Notable movers include ONL at USD 2.51 with a -1.95% change, ARE at USD 52.00 with a +1.68% change, and EXR at USD 139.72 with a +1.51% change.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App